Receptors of anthrax toxin and cell entry

Molecular Aspects of Medicine

Volumn 30, Issue 6, 2009, Pages 406-412

  van der Goot, Gisou ^a   Young, John A T ^b  

^a EPFL   (Switzerland)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Anthrax toxin; ARAP3; Endocytosis; LRP6; Receptors

Indexed keywords

ANTHRAX TOXIN; CAPILLARY MORPHOGENESIS PROTEIN 2; CELL RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MEMBRANE PROTEIN; TUMOR ENDOTHELIAL MARKER 8; UNCLASSIFIED DRUG;

BACILLUS ANTHRACIS; CHANNEL GATING; CYTOPLASM; ENDOCYTOSIS; HOST CELL; MOLECULAR MECHANICS; NONHUMAN; PH; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; ENDOCYTOSIS; ENDOSOMES; GTPASE-ACTIVATING PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN SUBUNITS; RECEPTORS, LDL; RECEPTORS, PEPTIDE;

EID: 70350728404     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2009.08.007     Document Type: Review

References (62)

1. Abrami L., Liu S., Cosson P., Leppla S.H., and van der Goot F.G. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160 3 (2003) 321-328
2. Abrami L., Lindsay M., Parton R.G., Leppla S.H., and van der Goot F.G. Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway. J. Cell Biol. 166 (2004) 645-651
3. Abrami L., Leppla S.H., and van der Goot F.G. Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J. Cell Biol. 172 2 (2006) 309-320
4. Abrami L., Kunz B., Deuquet J., Bafico A., Davidson G., and van der Goot F.G. Functional interactions between anthrax toxin receptors and the WNT signaling protein LRP6. Cell Microbiol. 10 (2008) 2509-2519
5. Alfano R.W., Leppla S.H., Liu S., Bugge T.H., Duesbery N.S., and Frankel A.E. Potent inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin: implications for broad anti-tumor efficacy. Cell Cycle 7 6 (2008) 745-749
6. Basha S., Rai P., Poon V., Saraph A., Gujraty K., Go M.Y., Sadacharan S., Frost M., Mogridge J., and Kane R.S. Polyvalent inhibitors of anthrax toxin that target host receptors. Proc. Natl. Acad. Sci. USA 103 36 (2006) 13509-13513
7. Bell S.E., Mavila A., Salazar R., Bayless K.J., Kanagala S., Maxwell S.A., and Davis G.E. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 114 Pt 15 (2001) 2755-2773
8. Bonuccelli G., Sotgia F., Frank P.G., Williams T.M., de Almeida C.J., Tanowitz H.B., Scherer P.E., Hotchkiss K.A., Terman B.I., Rollman B., Alileche A., Brojatsch J., and Lisanti M.P. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am. J. Physiol. Cell Physiol. 288 6 (2005) C1402-C1410
9. Bradley K.A., and Young J.A. Anthrax toxin receptor proteins. Biochem. Pharmacol. 65 3 (2003) 309-314
10. Bradley K.A., Mogridge J., Mourez M., Collier R.J., and Young J.A. Identification of the cellular receptor for anthrax toxin. Nature 414 6860 (2001) 225-229
11. Bradley K.A., Mogridge J., Jonah G., Rainey A., Batty S., and Young J.A. Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions. J. Biol. Chem. 278 49 (2003) 49342-49347
12. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., and St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 61 18 (2001) 6649-6655
13. Chen K.H., Liu S., Bankston L.A., Liddington R.C., and Leppla S.H. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J. Biol. Chem. 282 13 (2007) 9834-9845
14. Dal Molin F., Tonello F., Ladant D., Zornetta I., Zamparo I., Di Benedetto G., Zaccolo M., and Montecucco C. Cell entry and cAMP imaging of anthrax edema toxin. EMBO J. 25 22 (2006) 5405-5413
15. Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R., Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D., and Vande Woude G.F. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280 5364 (1998) 734-737
16. Falguieres T., Luyet P.P., and Gruenberg J. Molecular assemblies and membrane domains in multivesicular endosome dynamics. Exp. Cell Res. 315 9 (2009) 1567-1573
17. Go M.Y., Kim S., Partridge A.W., Melnyk R.A., Rath A., Deber C.M., and Mogridge J. Self-association of the transmembrane domain of an anthrax toxin receptor. J. Mol. Biol. 360 1 (2006) 145-156
18. Go M.Y., Chow E.M., and Mogridge J. The cytoplasmic domain of anthrax toxin receptor 1 affects binding of the protective antigen. Infect Immun. 77 1 (2009) 52-59
19. Gupta P.K., Moayeri M., Crown D., Fattah R.J., and Leppla S.H. Role of N-terminal amino acids in the potency of anthrax lethal factor. PLoS ONE 3 9 (2008) e3130
20. Haglund K., Shimokawa N., Szymkiewicz I., and Dikic I. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc. Natl. Acad. Sci. USA 99 19 (2002) 12191-12196
21. Hotchkiss K.A., Basile C.M., Spring S.C., Bonuccelli G., Lisanti M.P., and Terman B.I. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp. Cell Res. 305 1 (2005) 133-144
22. Inoue H., and Randazzo P.A. Arf GAPs and their interacting proteins. Traffic 8 11 (2007) 1465-1475
23. Kowanetz K., Husnjak K., Holler D., Kowanetz M., Soubeyran P., Hirsch D., Schmidt M.H., Pavelic K., De Camilli P., Randazzo P.A., and Dikic I. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. Mol. Biol. Cell 15 7 (2004) 3155-3166
24. Krugmann S., Anderson K.E., Ridley S.H., Risso N., McGregor A., Coadwell J., Davidson K., Eguinoa A., Ellson C.D., Lipp P., Manifava M., Ktistakis N., Painter G., Thuring J.W., Cooper M.A., Lim Z.Y., Holmes A.B., Dove S.K., Michell R.H., Grewal A., Nazarian A., Erdjument-Bromage H., Tempst P., Stephens L.R., and Hawkins P.T. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices. Mol. Cell 9 1 (2002) 95-108
25. Krugmann S., Williams R., Stephens L., and Hawkins P.T. ARAP3 is a PI3K- and rap-regulated GAP for RhoA. Curr. Biol. 14 15 (2004) 1380-1384
26. Krugmann S., Andrews S., Stephens L., and Hawkins P.T. ARAP3 is essential for formation of lamellipodia after growth factor stimulation. J. Cell Sci. 119 Pt 3 (2006) 425-432
27. Lacy D.B., Wigelsworth D.J., Melnyk R.A., Harrison S.C., and Collier R.J. Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation. Proc. Natl. Acad. Sci. USA 101 36 (2004) 13147-13151
28. Lacy D.B., Wigelsworth D.J., Scobie H.M., Young J.A., and Collier R.J. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 101 17 (2004) 6367-6372
29. Leppla S.H. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79 10 (1982) 3162-3166
30. Liu S., and Leppla S.H. Cell surface tumor endothelium marker cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278 7 (2003) 5227-5234
31. Liu S., Leung H.J., and Leppla S.H. Characterization of the interaction between anthrax toxin and its cellular receptors. Cell Microbiol. 9 4 (2007) 977-987
32. Lu Q., Wei W., Kowalski P.E., Chang A.C., and Cohen S.N. EST-based genome-wide gene inactivation identifies ARAP3 as a host protein affecting cellular susceptibility to anthrax toxin. Proc. Natl. Acad. Sci. USA (2004)
33. Maldonado-Arocho F.J., Fulcher J.A., Lee B., and Bradley K.A. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol. Microbiol. 61 2 (2006) 324-337
34. Moayeri M., and Leppla S.H. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7 1 (2004) 19-24
35. Mogridge J., Cunningham K., and Collier R.J. Stoichiometry of anthrax toxin complexes. Biochemistry 41 3 (2002) 1079-1082
36. Nanda A., Carson-Walter E.B., Seaman S., Barber T.D., Stampfl J., Singh S., Vogelstein B., Kinzler K.W., and St Croix B. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res. 64 3 (2004) 817-820
37. Panchal R.G., Halverson K.M., Ribot W., Lane D., Kenny T., Abshire T.G., Ezzell J.W., Hoover T.A., Powell B., Little S., Kasianowicz J.J., and Bavari S. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J. Biol. Chem. 280 11 (2005) 10834-10839
38. Pinson K.I., Brennan J., Monkley S., Avery B.J., and Skarnes W.C. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407 6803 (2000) 535-538
39. Raiborg C., and Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458 7237 (2009) 445-452
40. Rainey G.J., Wigelsworth D.J., Ryan P.L., Scobie H.M., Collier R.J., and Young J.A. Receptor-specific requirements for anthrax toxin delivery into cells. Proc. Natl. Acad. Sci. USA 102 37 (2005) 13278-13283
41. Rajapaksha M., Eichler J.F., Hajduch J., Anderson D.E., Kirk K.L., and Bann J.G. Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR. Protein Sci. 18 1 (2009) 17-23
42. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16 10 (2006) 522-529
43. Rmali K.A., Al-Rawi M.A., Parr C., Puntis M.C., and Jiang W.G. Upregulation of tumour endothelial marker-8 by interleukin-1beta and its impact in IL-1beta induced angiogenesis. Int. J. Mol. Med. 14 1 (2004) 75-80
44. Ryan P.L., and Young J.A. Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. PLoS ONE 3 3 (2008) e1817
45. Santelli E., Bankston L.A., Leppla S.H., and Liddington R.C. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature 430 7002 (2004) 905-908
46. Schneemann A., and Manchester M. Monoclonal antibody therapies for anthrax. Future Microbiol. 4 (2009) 35-43
47. Scobie H.M., Rainey G.J., Bradley K.A., and Young J.A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc.Natl. Acad. Sci. USA 100 9 (2003) 5170-5174
48. Scobie H.M., Thomas D., Marlett J.M., Destito G., Wigelsworth D.J., Collier R.J., Young J.A., and Manchester M. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. J. Infect Dis. 192 6 (2005) 1047-1051
49. Scobie H.M., Wigelsworth D.J., Marlett J.M., Thomas D., Rainey G.J., Lacy D.B., Manchester M., Collier R.J., and Young J.A. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog. 2 10 (2006) e111
50. Scobie H.M., Marlett J.M., Rainey G.J., Lacy D.B., Collier R.J., and Young J.A. Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation. PLoS ONE 2 3 (2007) e329
51. Sharma S., Thomas D., Marlett J., Manchester M., and Young J.A. Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor. Antimicrob. Agents Chemother. 53 3 (2009) 1210-1212
52. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., and Kinzler K.W. Genes expressed in human tumor endothelium. Science 289 5482 (2000) 1197-1202
53. Stacey T.T., Nie Z., Stewart A., Najdovska M., Hall N.E., He H., Randazzo P.A., and Lock P. ARAP3 is transiently tyrosine phosphorylated in cells attaching to fibronectin and inhibits cell spreading in a RhoGAP-dependent manner. J. Cell Sci. 117 Pt 25 (2004) 6071-6084
54. Tamai K., Semenov M., Kato Y., Spokony R., Liu C., Katsuyama Y., Hess F., Saint-Jeannet J.P., and He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 407 6803 (2000) 530-535
55. Tamai K., Zeng X., Liu C., Zhang X., Harada Y., Chang Z., and He X. A mechanism for Wnt coreceptor activation. Mol. Cell 13 1 (2004) 149-156
56. Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M., and Montecucco C. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248 3 (1998) 706-711
57. Vuyisich M., Gnanakaran S., Lovchik J.A., Lyons C.R., and Gupta G. A dual-purpose protein ligand for effective therapy and sensitive diagnosis of anthrax. Protein J. 27 5 (2008) 292-302
58. Wei W., Lu Q., Chaudry G.J., Leppla S.H., and Cohen S.N. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124 6 (2006) 1141-1154
59. Werner E., Kowalczyk A.P., and Faundez V. Anthrax toxin receptor 1/tumor endothelium marker eight mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J. Biol. Chem. 281 32 (2006) 23227-23236
60. Wigelsworth D.J., Krantz B.A., Christensen K.A., Lacy D.B., Juris S.J., and Collier R.J. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J. Biol. Chem. 279 22 (2004) 23349-23356
61. Wolfe J.T., Krantz B.A., Rainey G.J., Young J.A., and Collier R.J. Whole-cell voltage clamp measurements of anthrax toxin pore current. J. Biol. Chem. 280 47 (2005) 39417-39422
62. Young J.J., Bromberg-White J.L., Zylstra C., Church J.T., Boguslawski E., Resau J.H., Williams B.O., and Duesbery N.S. LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog. 3 3 (2007) e27